Comparative Pharmacology of the 3 Marketed Dual Orexin Antagonists—Daridorexant, Lemborexant, and Suvorexant: Part 1: Pharmacokinetic Profiles : Journal of Psychiatric Practice®

Secondary Logo

Journal Logo

You can read the full text of this article if you:

Access through Ovid
Columns

Comparative Pharmacology of the 3 Marketed Dual Orexin Antagonists—Daridorexant, Lemborexant, and Suvorexant: Part 1: Pharmacokinetic Profiles

Preskorn, Sheldon H. MD

Author Information
Journal of Psychiatric Practice: November 2022 - Volume 28 - Issue 6 - p 478-480
doi: 10.1097/PRA.0000000000000672
  • Buy

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.